K-numberK242295
Device nameBunkerHill BMD
ApplicantBunkerHill Health
Product codeKGI
Device classClass II
Decision dateApr 8, 2025
DecisionSubstantially Equivalent
Regulation892.1170
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Bunkerhill BMD is a software-only medical device using deep-learning algorithms to estimate bone mineral density from existing CT scan images. It is intended for adults 30 years and above to assess spinal bone density and flag low bone density below a pre-specified threshold, supporting opportunistic retrospective bone density assessment without requiring dedicated imaging or a phantom.

Technological characteristics

Both the subject and predicate devices use deep-learning algorithms to estimate average bone mineral density from CT images in DICOM format, serve as clinical decision-support tools without replacing clinical evaluation, and generate calibrated BMD reports with T-scores and Z-scores. The subject device provides a subset of predicate outputs (T-score group only) and automatically measures Hounsfield units across spinal bone regions of interest. Both have identical product code (KGI), regulation number (21 CFR 892.1170), and modality (computed tomography).

Test standards cited

Not stated in this summary.

Substantial equivalence argument

Bunkerhill BMD achieves substantial equivalence because it shares the same intended use, indications, technological principles, and regulatory classification as the predicate ABMD device. Both use identical deep-learning methodology for spinal bone density estimation from DICOM CT images and serve as physician support tools rather than replacements for clinical judgment. The subject device's validation study demonstrates sensitivity of 81.0% and specificity of 78.4% across 371 CT studies from geographically diverse sites with consistent performance across patient subgroups (age, sex, CT manufacturer, slice thickness, reconstruction kernel), and the minor differences in output scope do not introduce new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →